Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$18.80 +0.56 (+3.10%)
At close: Sep 30, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) EV to CFO (2021 - 2022)

Updated

Syndax Pharmaceuticals' EV to CFO was 57.04 in Q1 2022, up 117.6% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) EV to CFO (2021 - 2022) Analysis & Trends

On a trailing twelve-month basis, Syndax Pharmaceuticals' EV to CFO was -37.26 through Mar 31, 2022; for FY2021, it came in at 26.21.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Syndax Pharmaceuticals 1.63 Bn -103.87 Mn 69.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 57.04
Dec 31, 2021 26.21
API Access

Syndax Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SNDX&period=max&api_key=YOUR_API_KEY